Comparing Single Versus Repeat NMT on the Diversity of the Neonatal Nasal Microbiome

Recruiting

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Johns Hopkins University, Baltimore, Maryland